MSK Research Highlights September 18, 2024
New MSK research uses saturation genome editing to better understanding of the RAD51C gene, which has been linked to higher risks of breast and ovarian cancer; sheds new light on brain metastasis; and finds a commercially available contrast dye could help surgeons better separate cancer from healthy tissue.
In the Lab
Breaking Up Is Hard to Do (Especially for Sex Chromosomes)
One’s big, one’s small. Somehow, they make it work.
In the Lab
Molecular Studies Explain Effectiveness of Longtime Treatment for Prostate Cancer
Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.
Studies Provide New Insight into Fundamental Biological Process
Developmental biologist Maria Jasin studies homologous recombination, which is important in DNA repair and can lead to cancer when it malfunctions.
